These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31819302)

  • 1. Letrozole Effect on Final Height of Patients with Constitutional Delay of Growth and Puberty.
    Rohani F; Asadi R; Mirboluk AA; Soheilipour F
    Med Arch; 2019 Oct; 73(5):307-310. PubMed ID: 31819302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Müllerian hormone and letrozole levels in boys with constitutional delay of growth and puberty treated with letrozole or testosterone.
    Kohva E; Varimo T; Huopio H; Tenhola S; Voutilainen R; Toppari J; Miettinen PJ; Vaaralahti K; Viinamäki J; Backman JT; Hero M; Raivio T
    Hum Reprod; 2020 Feb; 35(2):257-264. PubMed ID: 31958337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with the aromatase inhibitor letrozole during adolescence increases near-final height in boys with constitutional delay of puberty.
    Hero M; Wickman S; Dunkel L
    Clin Endocrinol (Oxf); 2006 May; 64(5):510-3. PubMed ID: 16649968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letrozole versus testosterone for promotion of endogenous puberty in boys with constitutional delay of growth and puberty: a randomised controlled phase 3 trial.
    Varimo T; Huopio H; Kariola L; Tenhola S; Voutilainen R; Toppari J; Toiviainen-Salo S; Hämäläinen E; Pulkkinen MA; Lääperi M; Tarkkanen A; Vaaralahti K; Miettinen PJ; Hero M; Raivio T
    Lancet Child Adolesc Health; 2019 Feb; 3(2):109-120. PubMed ID: 30612946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, placebo-controlled comparison of letrozole to oxandrolone effects upon growth and puberty of children with constitutional delay of puberty and idiopathic short stature.
    Salehpour S; Alipour P; Razzaghy-Azar M; Ardeshirpour L; Shamshiri A; Monfared MF; Gharib A
    Horm Res Paediatr; 2010; 74(6):428-35. PubMed ID: 20628237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Letrozole in the Management of Constitutional Delay in Growth and Puberty: A Systematic Review and Meta-analysis.
    Dutta D; Singla R; Surana V; Sharma M
    J Clin Res Pediatr Endocrinol; 2022 Jun; 14(2):131-144. PubMed ID: 34477355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are short boys with constitutional delay of growth and puberty candidates for rGH therapy according to FDA recommendations?
    Krajewska-Siuda E; Malecka-Tendera E; Krajewski-Siuda K
    Horm Res; 2006; 65(4):192-6. PubMed ID: 16549932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutional delay of growth and puberty: from presentation to final height.
    Poyrazoğlu S; Günöz H; Darendeliler F; Saka N; Bundak R; Baş F
    J Pediatr Endocrinol Metab; 2005 Feb; 18(2):171-9. PubMed ID: 15751606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum testosterone and oestradiol predict the growth response during puberty promoting treatment.
    Huttunen H; Varimo T; Huopio H; Voutilainen R; Tenhola S; Miettinen PJ; Raivio T; Hero M
    Clin Endocrinol (Oxf); 2022 Feb; 96(2):220-226. PubMed ID: 34596269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Final height outcome in both untreated and testosterone-treated boys with constitutional delay of growth and puberty.
    Arrigo T; Cisternino M; Luca De F; Saggese G; Messina MF; Pasquino AM; De Sanctis V
    J Pediatr Endocrinol Metab; 1996; 9(5):511-7. PubMed ID: 8961126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of prolonged administration of an anabolic steroid (oxandrolone) on growth in boys with constitutionally delayed growth and puberty.
    Schroor EJ; van Weissenbruch MM; Knibbe P; Delemarre-van de Waal HA
    Eur J Pediatr; 1995 Dec; 154(12):953-7. PubMed ID: 8801102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letrozole vs anastrozole for height augmentation in short pubertal males: first year data.
    Neely EK; Kumar RB; Payne SL; Ranadive SA; Suchet DI
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4086-93. PubMed ID: 25137428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Final height in boys with untreated constitutional delay in growth and puberty.
    Crowne EC; Shalet SM; Wallace WH; Eminson DM; Price DA
    Arch Dis Child; 1990 Oct; 65(10):1109-12. PubMed ID: 2248500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life in boys with constitutional delay of growth and puberty.
    Kariola L; Varimo T; Huopio H; Tenhola S; Voutilainen R; Kosola S; Toppari J; Sintonen H; Miettinen PJ; Raivio T; Hero M
    Front Endocrinol (Lausanne); 2022; 13():1028828. PubMed ID: 36518253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial.
    Hero M; Norjavaara E; Dunkel L
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6396-402. PubMed ID: 16189252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive reduction of relative height in childhood predicts adult stature below target height in boys with constitutional delay of growth and puberty.
    Wehkalampi K; Vangonen K; Laine T; Dunkel L
    Horm Res; 2007; 68(2):99-104. PubMed ID: 17377395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on the role of aromatase inhibitors in growth disorders.
    Dunkel L
    Horm Res; 2009 Jan; 71 Suppl 1():57-63. PubMed ID: 19153508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A specific aromatase inhibitor and potential increase in adult height in boys with delayed puberty: a randomised controlled trial.
    Wickman S; Sipilä I; Ankarberg-Lindgren C; Norjavaara E; Dunkel L
    Lancet; 2001 Jun; 357(9270):1743-8. PubMed ID: 11403810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term treatment with low dose testosterone in constitutional delay of growth and puberty: effect on bone age maturation and pubertal progression.
    Bergadá I; Bergadá C
    J Pediatr Endocrinol Metab; 1995; 8(2):117-22. PubMed ID: 7584705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results of treatment with low-dose fluoxymesterone in constitutional delay of growth and puberty and in genetic short stature.
    Strickland AL
    Pediatrics; 1993 Apr; 91(4):716-20. PubMed ID: 8464656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.